Author(s): Gerner EW, Meyskens FL Jr, Gerner EW, Meyskens FL Jr
Abstract Share this page
Abstract The amino-acid-derived polyamines have long been associated with cell growth and cancer, and specific oncogenes and tumour-suppressor genes regulate polyamine metabolism. Inhibition of polyamine synthesis has proven to be generally ineffective as an anticancer strategy in clinical trials, but it is a potent cancer chemoprevention strategy in preclinical studies. Clinical trials, with well-defined goals, are now underway to evaluate the chemopreventive efficacy of inhibitors of polyamine synthesis in a range of tissues.
This article was published in Nat Rev Cancer
and referenced in Journal of Drug Metabolism & Toxicology